Added to YB: 2025-10-13
Pitch date: 2025-10-09
YPSN.SW [bullish]
Ypsomed Holding AG
-3.79%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies.
Market Cap
CHF 4.5B
Pitch Price
CHF 330.00
Price Target
N/A
Dividend
0.66%
EV/EBITDA
27.02
P/E
51.87
EV/Sales
6.37
Sector
Health Care Equipment and Supplies
Category
growth
Ypsomed (YPSN Switzerland): Conservative guidance hides a confident long game
YPSN.SW (quick overview): CMD guidance disappointed vs high expectations but mgmt under-promising vs peers over-promising. YDS segment well-positioned for healthcare megatrends, GLP-1 drug demand driving self-injection devices. 40+ clinical projects diversifying beyond Novo. Double-digit growth, expanding intl reach, margin expansion as capacity rises.
Read full article (2 min)